{
  "content": "The primary outcome was the time to the first recurrence of atrial fibrillation after sinus rhythm had been restored. Failed conversion was defined as the persistence of atrial fibrillation on day 28 (considered time 0). The expected rates of sustained sinus rhythm at one year were 60 percent in the amiodarone group, 50 percent in the sotalol group, and 35 percent in the placebo group. On the basis of these assumptions, the study had a statistical power of 85 percent to identify a significant difference in the Kaplanâ€“Meier time-to-event distributions between amiodarone and sotalol (two-sided alpha, 0.04), amiodarone and placebo (alpha, 0.005), and sotalol and placebo (alpha, 0",
  "source": "https://www.nejm.org/doi/full/10.1056/NEJMoa041705",
  "chunk_id": "dfc8b218-07af-4fc8-abec-5c18fa335f21",
  "similarity_score": 0.34045159816741943,
  "query": "long-term outcomes amiodarone beta-blockers atrial fibrillation follow-up recurrence maintenance therapy",
  "rank": 27,
  "title": "Amiodarone versus Sotalol for Atrial Fibrillation",
  "authors": "Bramah N. Singh, M.D., D.Sc., Steven N. Singh, M.D., Domenic J. Reda, Ph.D., X. Charlene Tang, M.D., Ph.D., Becky Lopez, R.N., Crystal L. Harris, Pharm.D., Ross D. Fletcher, M.D., Satish C. Sharma, M.D., J. Edwin Atwood, M.D., Alan K. Jacobson, M.D., H. Daniel Lewis, Jr., M.D., Dennis W. Raisch, Ph.D., Michael D. Ezekowitz, M.B., Ch.B., Ph.D.",
  "year": "2005",
  "journal": "New England Journal of Medicine",
  "reference": "Singh, B. N., Singh, S. N., Reda, D. J., Tang, X. C., Lopez, B., Harris, C. L., Fletcher, R. D., Sharma, S. C., Atwood, J. E., Jacobson, A. K., Lewis, H. D. Jr., Raisch, D. W., & Ezekowitz, M. D. (2005). Amiodarone versus sotalol for atrial fibrillation. New England Journal of Medicine, 352(18), 1861-1872. https://doi.org/10.1056/NEJMoa041705",
  "doi": "10.1056/NEJMoa041705",
  "chunk_index": 21,
  "total_chunks": 127,
  "retrieved_at": "2025-07-24T22:33:54.519326"
}